Sign in
4

Changes in Ownership

ANAPTYSBIO, INC Filed Acc 0001415889-24-023549

CHIEF FINANCIAL OFFICER sold 12,220 shares at an average $39.91 ($487,725)

  • CHIEF FINANCIAL OFFICER acquired 16,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MULROY DENNIS · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-14 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 6,964 D
2024-09-16 Sale : show line 2 in the form 10b5-1 −2,220 $38.93 $86,425 4,744 D
2024-09-16 Exercise or conversion : show line 3 in the form 10b5-1 +10,000 $20.16 $201,600 14,744 D
2024-09-16 Sale : show line 4 in the form 10b5-1 −10,000 $40.13 $401,300 4,744 D
Open-market sales · 12,220 sh · avg $39.91 · $487,725

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-14 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −6,000 0 D
2024-09-16 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) −10,000 80,600 D
Loading xslF345X05/form4-09172024_100933.xml…